This is a randomized, open label study to evaluate the efficacy and safety of calcitriol supplementation in COVID-19 patients with vitamin D deficiency.
This is a randomized, open label study to evaluate the efficacy (clinical and laboratory change)and safety (serum calcium) of calcitriol supplementation in COVID-19 patients with vitamin D deficiency.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
86
Calcitriol supplementation orally
Renji Hospital
Shanghai, Shanghai Municipality, China
The cycle threshold (Ct) value of COVID-19 nucleic acid after treatment
Nucleic acid test of COVID-19
Time frame: The 6th day after treatment
Clinical symptoms changes
fever, cough, sore throat,etc
Time frame: The 6th day after treatment
Laboratory examination changes
Complete Blood Count, inflammatory markers ,cytokines
Time frame: The 6th day after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.